Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Carolina Research Center, Inc.
mi
from
Shelby, NC
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Carolina Research Center, Inc.
mi
from
Shelby, NC
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Forest Investigative Site 011
mi
from
Hoffman Estates, IL
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 011
mi
from
Hoffman Estates, IL
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Forest Investigative Site 021
mi
from
Greenwood, IN
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 021
mi
from
Greenwood, IN
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Forest Investigative Site 001
mi
from
Shreveport, LA
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 001
mi
from
Shreveport, LA
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Forest Investigative Site 006
mi
from
Rockville, MD
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 006
mi
from
Rockville, MD
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
CRI Worldwide
mi
from
Mt Laurel, NJ
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
CRI Worldwide
mi
from
Mt Laurel, NJ
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Neuro-Pain Medical Center
mi
from
Fresno, CA
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Neuro-Pain Medical Center
mi
from
Fresno, CA
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Forest Investigative Site 004
mi
from
Irving, TX
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 004
mi
from
Irving, TX
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Lincoln Medical Center
mi
from
Lincoln, NE
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Lincoln Medical Center
mi
from
Lincoln, NE
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Chesapeake Clinical Research, Inc
mi
from
Baltimore, MD
Safety and Efficacy of Cariprazine for Bipolar I Disorder
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Chesapeake Clinical Research, Inc
mi
from
Baltimore, MD
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Tipton Medical and Diagnostic Center
mi
from
Tipton, PA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Tipton Medical and Diagnostic Center
mi
from
Tipton, PA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 010
mi
from
Costa Mesa, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 009
mi
from
Orange, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 009
mi
from
Orange, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
CRI Worldwide, LLC
mi
from
Philadelphia, PA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 016
mi
from
San Diego, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 016
mi
from
San Diego, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 007
mi
from
San Diego, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 007
mi
from
San Diego, CA
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 007
mi
from
Washington,
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 007
mi
from
Washington,
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 001
mi
from
Bradenton, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 001
mi
from
Bradenton, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 006
mi
from
Ft. Lauderdale, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 006
mi
from
Ft. Lauderdale, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site
mi
from
Kissimmee, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Kissimmee, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site
mi
from
Tampa, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Tampa, FL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 006
mi
from
Rockville, MD
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 006
mi
from
Rockville, MD
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
CRI Worldwide
mi
from
Mt Laurel, NJ
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
CRI Worldwide
mi
from
Mt Laurel, NJ
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 025
mi
from
St. Louis, MO
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 025
mi
from
St. Louis, MO
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 012
mi
from
Las Vegas, NV
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 012
mi
from
Las Vegas, NV
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 002
mi
from
Willingboro, NJ
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 002
mi
from
Willingboro, NJ
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 005
mi
from
Cincinnati, OH
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 005
mi
from
Cincinnati, OH
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 056
mi
from
Oklahoma City, OK
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 056
mi
from
Oklahoma City, OK
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 014
mi
from
Austin, TX
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 014
mi
from
Austin, TX
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 022
mi
from
Creve Coeur, MO
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 022
mi
from
Creve Coeur, MO
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Forest Investigative Site 009
mi
from
Chicago, IL
Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site 009
mi
from
Chicago, IL
Pilot of Acupuncture to Improve Quality of Life in Veterans With Traumatic Brain Injury (TBI) and Post-Traumatic Stress Disorder (PTSD)
Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD
Status: Archived
East Orange VA Medical Center Health Care System
mi
from
East Orange, NJ
Pilot of Acupuncture to Improve Quality of Life in Veterans With Traumatic Brain Injury (TBI) and Post-Traumatic Stress Disorder (PTSD)
Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD
Status: Archived
Updated: 1/1/1970
East Orange VA Medical Center Health Care System
mi
from
East Orange, NJ
Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance
Post-ICU Neurocognitive Performance and Sleep Quality Ratings Following Exposure to a Medical ICU Sleep Quality Improvement Project
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance
Post-ICU Neurocognitive Performance and Sleep Quality Ratings Following Exposure to a Medical ICU Sleep Quality Improvement Project
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
CT-FIRST: Cardiac Computed Tomography Versus Stress Imaging For Initial Risk STratification
CT-FIRST: Cardiac Computed Tomography Versus Stress Imaging For Initial Risk STratification
Status: Archived
Walter Reed Army Medical Center
mi
from
Washington,
CT-FIRST: Cardiac Computed Tomography Versus Stress Imaging For Initial Risk STratification
CT-FIRST: Cardiac Computed Tomography Versus Stress Imaging For Initial Risk STratification
Status: Archived
Updated: 1/1/1970
Walter Reed Army Medical Center
mi
from
Washington,
Investigation of Cycloserine as a Smoking Cessation Treatment
Cycloserine Enhancement of Extinction Learning
Status: Archived
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
Investigation of Cycloserine as a Smoking Cessation Treatment
Cycloserine Enhancement of Extinction Learning
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine
The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine
Status: Archived
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine
The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
NAC as a Potential Treatment for Methamphetamine Dependence
N-AcetylCysteine As a Potential Treatment of Methamphetamine Dependence
Status: Archived
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
NAC as a Potential Treatment for Methamphetamine Dependence
N-AcetylCysteine As a Potential Treatment of Methamphetamine Dependence
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Birmingham, AL
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Birmingham, AL
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Denver, CO
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Denver, CO
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Celebration, FL
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Centralia, IL
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Centralia, IL
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Jeffersonville, IN
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jeffersonville, IN
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Kansas City, KA
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Kansas City, KA
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Metairie, LA
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Metairie, LA
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Chevy Chase, MD
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Chevy Chase, MD
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Jackson, MS
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jackson, MS
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
St Louis, MO
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
St Louis, MO
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Albany, NY
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Clinical Trial Facility
mi
from
Charlotte, NC
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC